445 related articles for article (PubMed ID: 15703507)
1. The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care--cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record.
Rabinowitz I; Tamir A
Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):56-62. PubMed ID: 15703507
[TBL] [Abstract][Full Text] [Related]
2. [Hypertension management in general practice in Iceland].
Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
[TBL] [Abstract][Full Text] [Related]
3. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease risk factor assessment and management in gout: an analysis using guideline-based electronic clinical decision support.
Colvine K; Kerr AJ; McLachlan A; Gow P; Kumar S; Ly J; Wiltshire C; Robinson E; Dalbeth N
N Z Med J; 2008 Nov; 121(1285):73-81. PubMed ID: 19079439
[TBL] [Abstract][Full Text] [Related]
5. Follow-up in a lipid clinic improves the management of risk factors in cardiovascular disease patients.
Gavish D; Leibovitz E; Elly I; Shargorodsky M; Zimlichman R
Isr Med Assoc J; 2002 Sep; 4(9):694-7. PubMed ID: 12440233
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular protection paradigms: is change on the horizon?
Papademetriou V
Rev Cardiovasc Med; 2007; 8(4):200-13. PubMed ID: 18192943
[TBL] [Abstract][Full Text] [Related]
7. [Implementation of clinical guidelines in general practice. The effect of journal audit and continuing education for the treatment of cardiovascular risk factors in patients with and without type 2 diabetes].
Madsbad S; Larsen ML; Adeler HF; Kryhlmand M; Westergaard M
Ugeskr Laeger; 2006 Apr; 168(17):1640-5. PubMed ID: 16674875
[TBL] [Abstract][Full Text] [Related]
8. The Bold Promise Project: a system change in primary care to support cardiovascular risk screening.
Sinclair G; Kerr A
N Z Med J; 2006 Nov; 119(1245):U2312. PubMed ID: 17146487
[TBL] [Abstract][Full Text] [Related]
9. National study of physician awareness and adherence to cardiovascular disease prevention guidelines.
Mosca L; Linfante AH; Benjamin EJ; Berra K; Hayes SN; Walsh BW; Fabunmi RP; Kwan J; Mills T; Simpson SL
Circulation; 2005 Feb; 111(4):499-510. PubMed ID: 15687140
[TBL] [Abstract][Full Text] [Related]
10. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
Wachtel TM; Kucia AM; Greenhill JA
Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
[TBL] [Abstract][Full Text] [Related]
11. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
[TBL] [Abstract][Full Text] [Related]
12. Treatment of 5413 hypertensive patients: a cross-sectional study.
Paulsen MS; Sondergaard J; Reuther L; Larsen PS; Munck AP; Larsen PV; Damsgaard J; Poulsen L; Hansen DG; Jacobsen IA; Larsen ML; Christensen HR; Christensen B; Andersen M
Fam Pract; 2011 Dec; 28(6):599-607. PubMed ID: 21596691
[TBL] [Abstract][Full Text] [Related]
13. Underuse of American College of Cardiology/American Heart Association Guidelines in hemodialysis patients.
Gowdak LH; Arantes RL; de Paula FJ; Krieger EM; De Lima JJ
Ren Fail; 2007; 29(5):559-65. PubMed ID: 17654318
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hypercholesterolemia in patients with diabetes at a family practice office.
Camenga D; Gill JM
Del Med J; 2003 Nov; 75(11):415-20. PubMed ID: 14870630
[TBL] [Abstract][Full Text] [Related]
15. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk management at a Maori-led Primary Health Organisation--findings from a cross-sectional audit.
Peiris D; Murray J; Scully D; Tilakawardene V; Hetaraka-Stevens L; Stewart T; Patel A
N Z Med J; 2008 Nov; 121(1285):35-46. PubMed ID: 19079435
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular secondary prevention: patients' knowledge of cardiovascular risk factors and their attitude to reduce the risk burden, and the practice of family doctors. The "Help Your Heart Stay Young" study.
Celentano A; Palmieri V; Arezzi E; Sabatella M; Guillaro B; Brancati C; Piccinocchi G; Minichiello S; Russo C; Pezzullo S; Tufano A; Finelli L; Panico S; Di Minno G
Ital Heart J; 2004 Oct; 5(10):767-73. PubMed ID: 15626274
[TBL] [Abstract][Full Text] [Related]
19. Management of type 2 diabetes mellitus: is it in accordance with the guidelines?
Chan GC; Ghazali O; Khoo EM
Med J Malaysia; 2005 Dec; 60(5):578-84. PubMed ID: 16515108
[TBL] [Abstract][Full Text] [Related]
20. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
